Literature DB >> 21795705

Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation.

Joong-Youn Shim1, Alexander C Bertalovitz, Debra A Kendall.   

Abstract

The classical cannabinoid agonist HU210, a structural analog of (-)-Δ(9)-tetrahydrocannabinol, binds to brain cannabinoid (CB1) receptors and activates signal transduction pathways. To date, an exact molecular description of the CB1 receptor is not yet available. Utilizing the minor binding pocket of the CB1 receptor as the primary ligand interaction site, we explored HU210 binding using lipid bilayer molecular dynamics (MD) simulations. Among the potential ligand contact residues, we identified residues Phe-174(2.61), Phe-177(2.64), Leu-193(3.29), and Met-363(6.55) as being critical for HU210 binding by mutational analysis. Using these residues to guide the simulations, we determined essential cannabinoid-binding domains in the CB1 receptor, including the highly sought after hydrophobic pocket important for the binding of the C3 alkyl chain of classical and nonclassical cannabinoids. Analyzing the simulations of the HU210-CB1 receptor complex, the CP55940-CB1 receptor complex, and the (-)-Δ(9)-tetrahydrocannabinol-CB1 receptor complex, we found that the positioning of the C3 alkyl chain and the aromatic stacking between Trp-356(6.48) and Trp-279(5.43) is crucial for the Trp-356(6.48) rotamer change toward receptor activation through the rigid-body movement of H6. The functional data for the mutant receptors demonstrated reductions in potency for G protein activation similar to the reductions seen in ligand binding affinity for HU210.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795705      PMCID: PMC3190901          DOI: 10.1074/jbc.M111.261651

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

1.  Constitutive activation of the beta2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment.

Authors:  J A Javitch; D Fu; G Liapakis; J Chen
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition.

Authors:  Sean D McAllister; Qing Tao; Judy Barnett-Norris; Kurt Buehner; Dow P Hurst; Frank Guarnieri; Patricia H Reggio; Katharine W Nowell Harmon; Guy A Cabral; Mary E Abood
Journal:  Biochem Pharmacol       Date:  2002-06-15       Impact factor: 5.858

3.  Steric trigger as a mechanism for CB1 cannabinoid receptor activation.

Authors:  Joong-Youn Shim; Allyn C Howlett
Journal:  J Chem Inf Comput Sci       Date:  2004 Jul-Aug

4.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

5.  Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.

Authors:  B R Martin; R Jefferson; R Winckler; J L Wiley; J W Huffman; P J Crocker; B Saha; R K Razdan
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

6.  Cannabinoids. Structure-activity studies related to 1,2-dimethylheptyl derivatives.

Authors:  B Loev; P E Bender; F Dowalo; E Macko; P J Fowler
Journal:  J Med Chem       Date:  1973-11       Impact factor: 7.446

7.  Distinct second extracellular loop structures of the brain cannabinoid CB(1) receptor: implication in ligand binding and receptor function.

Authors:  Joong-Youn Shim; James Rudd; Tomas T Ding
Journal:  Proteins       Date:  2011-02

8.  Cysteine residues in the human cannabinoid receptor: only C257 and C264 are required for a functional receptor, and steric bulk at C386 impairs antagonist SR141716A binding.

Authors:  Jonathan F Fay; Thomas D Dunham; David L Farrens
Journal:  Biochemistry       Date:  2005-06-21       Impact factor: 3.162

9.  Light activation of rhodopsin: insights from molecular dynamics simulations guided by solid-state NMR distance restraints.

Authors:  Viktor Hornak; Shivani Ahuja; Markus Eilers; Joseph A Goncalves; Mordechai Sheves; Philip J Reeves; Steven O Smith
Journal:  J Mol Biol       Date:  2009-12-11       Impact factor: 5.469

10.  Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.

Authors:  L S Melvin; G M Milne; M R Johnson; B Subramaniam; G H Wilken; A C Howlett
Journal:  Mol Pharmacol       Date:  1993-11       Impact factor: 4.436

View more
  12 in total

1.  Identification and characterization of nucleobase-modified aptamers by click-SELEX.

Authors:  Franziska Pfeiffer; Fabian Tolle; Malte Rosenthal; Gerhard Markus Brändle; Jörg Ewers; Günter Mayer
Journal:  Nat Protoc       Date:  2018-04-26       Impact factor: 13.491

2.  Probing the interaction of SR141716A with the CB1 receptor.

Authors:  Joong-Youn Shim; Alexander C Bertalovitz; Debra A Kendall
Journal:  J Biol Chem       Date:  2012-09-20       Impact factor: 5.157

3.  Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis.

Authors:  Jye-Lin Hsu; Woei-Jer Chuang; Ih-Jen Su; Wen-Jun Gui; Yu-Ying Chang; Yun-Ping Lee; Yu-Lin Ai; David T Chuang; Wenya Huang
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

4.  Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gαiβγ: identification of key CB1 contacts with the C-terminal helix α5 of Gαi.

Authors:  Joong-Youn Shim; Kwang H Ahn; Debra A Kendall
Journal:  J Biol Chem       Date:  2013-10-03       Impact factor: 5.157

5.  Δ9 -Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARγ and CB1 receptors.

Authors:  Belén Palomares; Martín Garrido-Rodriguez; Claudia Gonzalo-Consuegra; María Gómez-Cañas; Suwipa Saen-Oon; Robert Soliva; Juan A Collado; Javier Fernández-Ruiz; Gaetano Morello; Marco A Calzado; Giovanni Appendino; Eduardo Muñoz
Journal:  Br J Pharmacol       Date:  2020-07-08       Impact factor: 8.739

6.  Structure of an allosteric modulator bound to the CB1 cannabinoid receptor.

Authors:  Zhenhua Shao; Wei Yan; Karen Chapman; Karthik Ramesh; Aaron J Ferrell; Jie Yin; Xuehui Wang; Qingping Xu; Daniel M Rosenbaum
Journal:  Nat Chem Biol       Date:  2019-10-28       Impact factor: 15.040

7.  High-resolution crystal structure of the human CB1 cannabinoid receptor.

Authors:  Zhenhua Shao; Jie Yin; Karen Chapman; Magdalena Grzemska; Lindsay Clark; Junmei Wang; Daniel M Rosenbaum
Journal:  Nature       Date:  2016-11-16       Impact factor: 49.962

Review 8.  Homology models of melatonin receptors: challenges and recent advances.

Authors:  Daniele Pala; Alessio Lodola; Annalida Bedini; Gilberto Spadoni; Silvia Rivara
Journal:  Int J Mol Sci       Date:  2013-04-12       Impact factor: 5.923

9.  Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor.

Authors:  Arhamatoulaye Maïga; Jon Merlin; Elodie Marcon; Céline Rouget; Maud Larregola; Bernard Gilquin; Carole Fruchart-Gaillard; Evelyne Lajeunesse; Charles Marchetti; Alain Lorphelin; Laurent Bellanger; Roger J Summers; Dana S Hutchinson; Bronwyn A Evans; Denis Servent; Nicolas Gilles
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

10.  The F238L Point Mutation in the Cannabinoid Type 1 Receptor Enhances Basal Endocytosis via Lipid Rafts.

Authors:  Melanie Wickert; Keri L Hildick; Gemma L Baillie; Ruth Jelinek; Alejandro Aparisi Rey; Krisztina Monory; Miriam Schneider; Ruth A Ross; Jeremy M Henley; Beat Lutz
Journal:  Front Mol Neurosci       Date:  2018-07-05       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.